 Localization malignant melanoma monoclonal antibodies screening test patients cancer occult metastatic disease disease goal research efforts Twenty-nine evaluable patients deeply invasive stage regional nodal stage II systemic stage III underwent imaging administration preparation antimelanoma antibody technetium Scan results confirmed metastatic sites technique sensitivity Analysis individual positive sites nodal basins visceral metastases percentage metastatic sites nodal basin metastases visceral metastases imaging Occult nodal disease iliac nodal chain patients imaging benign tumors nodal basins disease confirmed false-positive rate Three scan results false-negative vivo tumor localization monoclonal antibodies sensitivity similar roentgenographic procedures metastatic disease useful patients occult iliac nodal disease region difficult physical examination modalities